BUX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioMark Diagnostics Inc

Watchlist Manager

Watchlist

Price: 0.56 CAD 3.7% Market Closed

Market Cap: CA$59.6m

B	BioMark Diagnostics Inc CNSX:BUX	CA
P	Pliant Therapeutics Inc F:9PT	US
B	BCWorldPharm Co Ltd KOSDAQ:200780	KR
	Novus Holdings Ltd F:N09	ZA
	Copenhagen Airports A/S CSE:KBHL	DK
E	Electromagnetic Geoservices ASA XMUN:E2M	NO
	TransAct Technologies Inc NASDAQ:TACT	US
	Orora Ltd ASX:ORA	AU
	Cargojet Inc F:CJ8A	CA
B	Bureau Veritas SA DUS:4BV	FR
X	XPO Inc F:UX2A	US
A	Ads-Tec Energy PLC NASDAQ:ADSE	IE
A	Air Products and Chemicals Inc DUS:AP3	US
	Uni-President China Holdings Ltd HKEX:220	CN
	Interspace Co Ltd TSE:2122	JP
D	DRDGOLD Ltd XMUN:DUB1	ZA
	Aldebaran Resources Inc XTSX:ALDE	CA
	Dalaroo Metals Ltd OTC:DALMF	AU

Profitability Summary

BioMark Diagnostics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-6 783%

Negative 3Y Average Operating Margin

-1 925%

Declining Operating Margin

-1 028% > -6 783%

Negative Net Margin

-5 128%

Negative 3Y Average Net Margin

-1 617%

Declining Net Margin

-962% > -5 128%

Negative Free Cash Flow Margin

-3 834%

Negative 3Y Average Free Cash Flow Margin

-1 163%

Declining Free Cash Flow Margin

-374% > -3 834%

Negative ROE

-150%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-385%

ROIC is Increasing

-335% > -240%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.